Uric Acid May Mark Progression for Nasopharyngeal Cancer

Share this content:
Uric Acid May Mark Progression for Nasopharyngeal Cancer
Uric Acid May Mark Progression for Nasopharyngeal Cancer

FRIDAY, Dec. 30, 2016 (HealthDay News) -- There is a direct correlation between the pretreatment serum uric acid (SUA) level and tumor progression in patients with locally advanced nasopharyngeal carcinoma (NPC), according to a study published online Dec. 20 in Head & Neck.

Xiao-Jing Du, M.D., from the Sun Yat-sen University Cancer Center in Guangzhou, China, and colleagues retrospectively examined data from 1,063 patients with locally advanced NPC to determine the predictive value of pretreatment SUA.

The researchers found that high pretreatment SUA level (>353.4 µmol/L) independently predicted distant metastasis-free survival (P = 0.013). High pretreatment SUA also was associated with high white blood cell counts (P = 0.005), lymphocyte counts (P < 0.001), and male sex (P < 0.001). SUA levels were significantly elevated in patients with T1 to T3 classification (P = 0.042). Markedly higher pretreatment SUA levels were detected for patients with subsequent lung metastases after treatment versus patients who had other distant metastases (P = 0.012) and patients without distant metastasis (P = 0.024).

"Pretreatment SUA may be a useful biomarker for evaluating treatment options for patients with locally advanced NPC," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Gastric Acid Suppressants May Up Risk of Recurrent C. difficile

Gastric Acid Suppressants May Up Risk of Recurrent ...

Meta-analysis shows increased risk of recurrent CDI, even after adjustment for age and confounders

Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.

Paid Malpractice Claims Cut in Half From 1992 ...

But, increase in mean compensation amounts and percentage of paid claims exceeding $1 million

MRI-Based Strategy Reduces Biopsies in Prostate CA Screening

MRI-Based Strategy Reduces Biopsies in Prostate CA Screening

MRI-based screening could reduce unnecessary biopsies, overdiagnosis of low-grade cancer

is free, fast, and customized just for you!

Already a member?

Sign In Now »